You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 11, November 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 44TH ANNUAL CANCER SYMPOSIUM OF THE SOCIETY OF SURGICAL ONCOLOGY, ORLANDO, FLA, March 24-27, 1991-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (41)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Metastatic Melanoma of the Gastrointestinal Tract

Results of Surgical Management

Gregory G. Caputy, MD, PhD; John H. Donohue, MD; John R. Goellner, MD; Amy L. Weaver, MS

Arch Surg. 1991;126(11):1353-1358.


Abstract

• Between 1954 and 1989, 41 patients with melanoma metastatic to the gastrointestinal tract underwent surgical treatment at the Mayo Clinic, Rochester, Minn. The small bowel was most commonly involved (71%), followed by the stomach (27%), large bowel (22%), and esophagus (5%). Gross total excision of all intra-abdominal metastases was performed in 52% of patients. The postoperative mortality was 5% and the median patient survival was 0.8 years, with 1- and 5-year survival rates of 44% and 9%, respectively. Of the patient, tumor, and treatment variables evaluated, patients with small-intestinal metastases had a significantly worse prognosis. Although patients with melanoma metastatic to the bowel have a limited life expectancy, surgical resection of their metastases provides effective palliation. Operative treatment of selected patients with symptomatic melanoma metastatic to the gastrointestinal tract is a worthwhile undertaking.

(Arch Surg. 1991;126:1353-1358)



Author Affiliations

From the Departments of Surgery (Drs Caputy and Donohue) and Pathology (Dr Goellner) and the Section of Biostatistics (Ms Weaver), Mayo Clinic, Rochester, Minn. Dr Caputy is now with the Department of Plastic Surgery, Dalhousie University, Halifax, Nova Scotia.


Footnotes

Accepted for publication August 4, 1991.

Presented at the 44th Annual Cancer Symposium of the Society of Surgical Oncology, Orlando, Fla, March 25, 1991.

Reprint requests to the Department of Surgery, Mayo Clinic, Rochester, MN 55905 (Dr Donohue).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Metastatic Malignant Melanoma of the Gastrointestinal Tract
Liang et al.
Mayo Clin Proc. 2006;81:511-516.
ABSTRACT | FULL TEXT  

Surgical Resection for Melanoma Metastatic to the Gastrointestinal Tract
Ollila et al.
Arch Surg 1996;131:975-980.
ABSTRACT  

Malignant Melanoma Metastatic to Gastrointestinal Tract: A Clinicopathologic Study
Adair et al.
INT J SURG PATHOL 1994;2:3-9.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.